Colgate

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Colgate 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CL

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. 

CEO
Noel R. Wallace
CEONoel R. Wallace
Employees
33,600
Employees33,600
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1806
Founded1806
Employees
33,600
Employees33,600

CL Key Statistics

Market cap
67.60B
Market cap67.60B
Price-Earnings ratio
32.09
Price-Earnings ratio32.09
Dividend yield
2.47%
Dividend yield2.47%
Average volume
5.83M
Average volume5.83M
High today
$86.50
High today$86.50
Low today
$84.08
Low today$84.08
Open price
$85.99
Open price$85.99
Volume
3.74M
Volume3.74M
52 Week high
$99.33
52 Week high$99.33
52 Week low
$74.55
52 Week low$74.55

Stock Snapshot

The current Colgate(CL) stock price is $84.42, with a market capitalization of 67.6B. The stock trades at a price-to-earnings (P/E) ratio of 32.09 and offers a dividend yield of 2.5%.

On 2026-04-11, Colgate(CL) stock traded between a low of $84.08 and a high of $86.50. Shares are currently priced at $84.42, which is +0.4% above the low and -2.4% below the high.

Colgate(CL) shares are trading with a volume of 3.74M, against a daily average of 5.83M.

In the last year, Colgate(CL) shares hit a 52-week high of $99.33 and a 52-week low of $74.55.

In the last year, Colgate(CL) shares hit a 52-week high of $99.33 and a 52-week low of $74.55.

CL News

TipRanks 1d
Colgate-Palmolive price target lowered to $102 from $105 at BofA

BofA analyst Peter Galbo lowered the firm’s price target on Colgate-Palmolive (CL) to $102 from $105 and keeps a Buy rating on the shares. Ahead of Q1 earnings,...

TipRanks 1d
Colgate-Palmolive: Maintaining Buy Rating on Defensive Strength and Premium Valuation Despite Near-Term Margin Headwinds

Bank of America Securities analyst Peter Galbo reiterated a Buy rating on Colgate-Palmolive today and set a price target of $102.00. Unlock hedge fund-level da...

TipRanks 2d
Colgate-Palmolive Announces Planned Chief Legal Officer Succession

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

52%

of 23 ratings
Buy
52.2%
Hold
43.5%
Sell
4.3%

More CL News

Simply Wall St 3d
Colgate-Palmolive Governance Proposals Could Be A Game Changer For Colgate-Palmolive

On March 25, 2026, Colgate-Palmolive disclosed that it had received two shareholder proposals, one seeking an independent board chair and another aiming to remo...

Colgate-Palmolive Governance Proposals Could Be A Game Changer For Colgate-Palmolive
Simply Wall St 6d
Colgate Palmolive Valuation Check As Mixed Returns Contrast With Premium P/E Multiple

Advertisement Colgate-Palmolive as a consumer staples anchor Colgate-Palmolive (CL) has drawn investor attention after recent trading left the shares at $85.1...

Colgate Palmolive Valuation Check As Mixed Returns Contrast With Premium P/E Multiple

People also own

Based on the portfolios of people who own CL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.